Unlocking The Potential of BHLHE23 as A Drug Target Or Biomarker

Target Name: BHLHE23

NCBI ID: G128408

BHLHE23

Unlocking The Potential of BHLHE23 as A Drug Target Or Biomarker

BHLHE23 (BETA4) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and function have made it an intriguing target for researchers to study.

The BHLHE23 gene is located on chromosome 16 and encodes for a protein known as BHLHE23. This protein is a key player in the regulation of cell growth and differentiation, and is involved in the development and maintenance of tissues such as brain, heart, and blood vessels.

Studies have shown that BHLHE23 is highly expressed in a variety of tissues, including cancer cells, and is involved in the regulation of cell proliferation, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels).

One of the key features of BHLHE23 is its ability to interact with other proteins, including the transcription factor, p53. This interaction between BHLHE23 and p53 has been shown to play a role in the regulation of cell growth and apoptosis.

In addition, BHLHE23 has also been shown to interact with the protein, PDGF-BB. This interaction between BHLHE23 and PDGF-BB has been linked to the regulation of cell proliferation and angiogenesis.

These interactions between BHLHE23 and other proteins have led researchers to believe that it may be a potential drug target or biomarker for various diseases.

One of the potential benefits of targeting BHLHE23 is its involvement in the regulation of cell growth and apoptosis. By inhibiting the activity of BHLHE23, researchers may be able to slow down or even reverse the growth of cancer cells.

Another potential benefit of targeting BHLHE23 is its involvement in the regulation of angiogenesis. By inhibiting the activity of BHLHE23, researchers may be able to reduce the formation of new blood vessels, which can be a source of cancer.

In addition, BHLHE23 has also been shown to be involved in the regulation of cell differentiation and tissue homeostasis. By modulating the activity of BHLHE23, researchers may be able to control the development and maintenance of tissues such as brain, heart, and blood vessels.

Overall, BHLHE23 is a gene that has a great deal of potential as a drug target or biomarker for various diseases. Its unique structure and function have made it an intriguing target for researchers to study, and further research is likely to uncover its many secrets.

Protein Name: Basic Helix-loop-helix Family Member E23

Functions: May function as transcriptional repressor. May modulate the expression of genes required for the differentiation and/or maintenance of pancreatic and neuronal cell types. May be important for rod bipolar cell maturation (By similarity)

The "BHLHE23 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BHLHE23 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets